In 2015, the American Thyroid Association (ATA) guidelines for the first time endorsed active surveillance (AS) as an alternative to immediate surgery in select patients with low-risk papillary thyroid cancer (PTC).1 To date, very few patients in the US are being treated with AS. The numbers of newly diagnosed patients with PTC who may be AS candidates in the coming years are not known.
Roman BR, Gupta P, Tuttle RM, Morris LGT, Lohia S. Assessing the Number of Candidates There Are for Active Surveillance of Low-Risk Papillary Thyroid Cancers in the US. JAMA Otolaryngol Head Neck Surg. Published online May 07, 2020. doi:10.1001/jamaoto.2020.0523
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: